Tobacco Assessment in Actively Accruing National Cancer Institute Cooperative Group Program Clinical Trials JUne 11, 2012.

Purpose Substantial evidence suggests that tobacco use has adverse effects on cancer treatment outcomes; however, routine assessment of tobacco use has not been fully incorporated into standard clinical oncology practice. The purpose of this study was to evaluate tobacco use assessment in patients enrolled onto actively accruing cancer clinical trials.

Methods Protocols and forms for 155 actively accruing trials in the National Cancer Institute’s (NCI’s) Clinical Trials Cooperative Group Program were evaluated for tobacco use assessment at enrollment and follow-up by using a structured coding instrument. Read More